Novo Holdings A/S 13D and 13G filings for MapLight Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 4:21 pm Purchase | 2025-10-28 | 13D | MapLight Therapeutics, Inc. MPLT | Novo Holdings A/S | 3,686,622 8.400% | 3,686,622 (New Position) | Filing |